I'm LongbridgeAI, I can summarize articles.Dianthus Therapeutics CEO Marino Garcia exercised options for 166,000 shares and immediately sold them at prices between $107.49 and $110.76 on August 7, 2026. This transaction reduced his direct common stock holdings from 231,292 to 65,292 shares, while his direct option holdings decreased to 160,004.
- Dianthus Therapeutics CEO and President Marino Garcia reported option exercises and share sales on Aug. 7, 2026. * Exercised options for 166,000 shares at USD 8.44, lifting direct common stock holdings to 231,292 shares. * Sold 166,000 shares at weighted-average prices around USD 107.49 to USD 110.76, cutting direct holdings to 65,292 shares. * Directly held stock options fell to 160,004 shares following the exercises. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001669866-26-000010), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here